A carregar...
A novel 4-gene prognostic signature for hypermutated colorectal cancer
BACKGROUND: Hypermutated colorectal cancer (CRC) reportedly accounts for 15%–17% of all cases of CRC. However, the proportion and number of patients with hypermutated CRC cannot be unappreciated. Additionally, therapy options for these patients differ from those for CRC patients, with a greater pote...
Na minha lista:
| Publicado no: | Cancer Manag Res |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6407520/ https://ncbi.nlm.nih.gov/pubmed/30881123 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S190963 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|